Hear about the special
features of this program and listen to a preview of course content!
In 2007, the American College of Chest Physicians released an update to the treatment guidelines for Pulmonary Arterial Hypertension (PAH), based on recent clinical developments. This latest update provides evidence-based treatment recommendations for physicians involved in the care of patients with PAH. The symptoms of PAH are nonspecific and many patients are labeled by healthcare providers with an incorrect diagnosis for several years before PAH is correctly diagnosed. Symptoms are generally due to impaired oxygen transport and decreased cardiac output. Dyspnea is present in most PAH patients at the time of presentation. Exercise intolerance is a frequent complaint and has an insidious onset in most patients. The importance of a thorough diagnostic evaluation to distinguish PAH from venous, hypoxic, thromboembolic, or miscellaneous varieties of pulmonary hypertension is paramount to establishing a plan of care. This program will assist you in accurate diagnosis of PAH and in treating your patients using the most recent clinical guidelines.
Faculty: Nicholas S. Hill, MD Reviewer: Robin J. Trupp PhD, APRN, FAHA
This course provides the latest insights into the pathogenesis, classification, and prognosis of pulmonary arterial hypertension and how they relate to the diagnosis and treatment of the condition.
This self-study activity should be completed in approximately 15 minutes.
Faculty: Nicholas S. Hill, MD Reviewer: Robin J. Trupp PhD, APRN, FAHA
Based on current practice guidelines, this course details recommended diagnostic strategies for the evaluation of patients with pulmonary arterial hypertension.
This self-study activity should be completed in approximately 30 minutes.
Faculty: Nicholas S. Hill, MD Reviewer: Robin J. Trupp PhD, APRN, FAHA
Using the Rapid Cycle Performance Improvement (RCPI) model this course will assist you in planning and implementing a performance improvement project in your practice.
This self-study activity should be completed in approximately 45 minutes.
This CME activity is designated for pulmonologists, cardiologists, rheumatologists, nurses and other healthcare professionals involved with pulmonary patients.
MEBN is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Credits
MEBN designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
FDA Disclosure Statement
The contents of some CME activities may contain discussions of non-approved or off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
Accreditation Period
Release Date: December 31, 2009 End Date: December 31, 2011
Any questions regarding the accreditation of this CME activity should be directed to MEBN. (accreditation@mebn.net)
Continuing Education for Nurses MEBN is an approved provider of continuing nursing education by the New Hampshire Nurses’ Association Commission on Continuing Education, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. MEBN recognizes that the accredited status refers only to our continuing nursing education activities and does not imply that the ANCC Commission on Accreditation approves or endorses these commercial products.
Contact Hours MEBN designates this continuing education activity for up to 2.5 contact hour(s) of nursing continuing education credit.
Accreditation Period Release Date: December 31, 2009 End Date: December 31, 2011
This continuing education program may contain discussion of published and/or investigational uses of agents or products that are not approved by the Food and Drug Administration (FDA). The authors, sponsors or publishers do not recommend the use of any agent or product outside of the official labeled indications. Please refer to the official prescribing information for each agent or product for discussion of approved indications, contraindications, and written warnings.
Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this course should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
The authors, contributors, and editorial staff have made every effort to contact holders of copyright to obtain permission to reproduce copyright material. However, if any permissions have been inadvertently overlooked, MEBN will be pleased to make the necessary and reasonable arrangements.
CME-TODAY offers FREE continuing medical education (CME) credits to recipients of the CD-ROM, program emails or CME-TODAY journal. Enter the CE Code listed on the CD-ROM, in the email or in the journal when prompted. This free offer expires on December 31, 2010. All others will be assessed a $15.95 processing fee.
